Clinical Trial Update: MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) [NA]

View source ↗

Summary

A ClinicalTrials.gov entry outlining a study comparing Moducare to a wait-and-see approach for histologically proven cervical intraepithelial neoplasia grade 1 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Moducare

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Low-grade Cervical Intraepithelial Neoplasia, Moducare | NA | Status: NOT_YET_RECRUITING